Yu Rao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yu Rao has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Chuan Li
Department of Orthopaedics, China-Japan Friendship Hospital, Beijing, China
2 shared publications Anmin Wang
Graduate School, Kunming Medical University 2
1 shared publicationBaochuang Qi
Orthopedic Trauma Center, Yunnan Provincial Hospital of Traditional Chinese Medicine/The First Affiliated Hospital of Yunnan University of Chinese Medicine, China
1 shared publicationChen Meng
Graduate school, Kunming Medical University, Kunming, 650500, Yunnan, China
1 shared publicationGaetan Drouin
Teagasc, Food Research Centre, Moorepark, Fermoy, Co. Cork, P61 C996, Ireland
1 shared publicationGonzalo Saiz-Gonzalo
APC Microbiome Ireland, Department of Medicine, University College Cork 3
1 shared publication
Latest Publications
- Open Access
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 73-96
A bioactive magnesium alloy scaffold integrated with BMSCs-Loaded 3D microspheres synergistically promotes femoral head osteonecrosis repair by improving the osteogenic-angiogenic microenvironment
Osteonecrosis of the Femoral Head (ONFH) is primarily characterized by impaired osteogenesis and insufficient vascularization, leading to progressive structural collapse and limb dysfunction. To develop a targeted strategy for regulating the bone-vascular microenvironment in hip preserving treatment, we integrated a three-dimensionally (3D) printed microporous magnesium alloy scaffold with bone marrow mesenchymal stem cells (BMSCs)-loaded 3D microspheres into a composite regenerative system. We then evaluated its therapeutic efficacy and investigated its underlying mechanisms. In vitro, the composite system demonstrated favorable biocompatibility and promoted osteogenic and angiogenic differentiation. In a steroid-induced rabbit model of femoral head necrosis, micro-CT and histological analysis confirmed the system's significant interventional effect. The magnesium alloy scaffold provided adequate mechanical support and released Mg2+ ions to participate in microenvironmental regulation. The BMSCs-loaded 3D microspheres were firmly integrated with the scaffold, which increased BMSCs loading capacity and provided a protective growth environment that shielded cells from mechanical damage. Further experiments indicated that the composite system modulated the interactions among BMSCs, osteoblasts, and vascular endothelial cells. By activating Extracellular Matrix organization, Focal adhesion, and the PI3K-Akt signaling pathways, it regulated the osteoblast and endothelial cell-related bone-vascular microenvironment to promote femoral head repair. This study demonstrates that combining a bioactive magnesium scaffold with BMSCs-loaded microspheres synergistically promotes femoral head repair, highlighting the therapeutic potential of integrating bioactive ion release with cellular paracrine regulation.
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 73-96
Open AccessA bioactive magnesium alloy scaffold integrated with BMSCs-Loaded 3D microspheres synergistically promotes femoral head osteonecrosis repair by improving the osteogenic-angiogenic microenvironment
Osteonecrosis of the Femoral Head (ONFH) is primarily characterized by impaired osteogenesis and insufficient vascularization, leading to progressive structural collapse and limb dysfunction. To develop a targeted strategy for regulating the bone-vascular microenvironment in hip preserving treatment, we integrated a three-dimensionally (3D) printed microporous magnesium alloy scaffold with bone marrow mesenchymal stem cells (BMSCs)-loaded 3D microspheres into a composite regenerative system. We then evaluated its therapeutic efficacy and investigated its underlying mechanisms. In vitro, the composite system demonstrated favorable biocompatibility and promoted osteogenic and angiogenic differentiation. In a steroid-induced rabbit model of femoral head necrosis, micro-CT and histological analysis confirmed the system's significant interventional effect. The magnesium alloy scaffold provided adequate mechanical support and released Mg2+ ions to participate in microenvironmental regulation. The BMSCs-loaded 3D microspheres were firmly integrated with the scaffold, which increased BMSCs loading capacity and provided a protective growth environment that shielded cells from mechanical damage. Further experiments indicated that the composite system modulated the interactions among BMSCs, osteoblasts, and vascular endothelial cells. By activating Extracellular Matrix organization, Focal adhesion, and the PI3K-Akt signaling pathways, it regulated the osteoblast and endothelial cell-related bone-vascular microenvironment to promote femoral head repair. This study demonstrates that combining a bioactive magnesium scaffold with BMSCs-loaded microspheres synergistically promotes femoral head repair, highlighting the therapeutic potential of integrating bioactive ion release with cellular paracrine regulation.
- 19 May 2026
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 214, 116128
Maternal rebaudioside A and acesulfame-K exposure reprograms offspring submandibular gland development in a sex-dependent manner
- 19 May 2026
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 214, 116128
Maternal rebaudioside A and acesulfame-K exposure reprograms offspring submandibular gland development in a sex-dependent manner
- Open Access
- 1 July 2025
- Published by Bioscientifica in EFORT Open Reviews
- Vol. 10 (7) , 496-509
Selection of experimental animals and modeling methods in developmental dysplasia of the hip research
Developmental dysplasia of the hip (DDH) is a common neonatal musculoskeletal condition characterized by hip instability and inadequate acetabular coverage. If untreated, it can lead to osteoarthritis, chronic pain, and eventual hip replacement. Animal models, including dogs, pigs, sheep, rabbits, rodents, and chickens, are essential tools for studying DDH pathogenesis and testing therapeutic strategies. Larger species closely resemble human anatomy, while smaller species facilitate cost-effective, high-throughput studies and advanced genetic manipulation. Key modeling strategies include surgical interventions (e.g. joint dislocation, femoral or pelvic osteotomy), external fixation, and genetic modifications (e.g. gene knockout or lentiviral transduction) to simulate various aspects of DDH and reflect its multifactorial etiology. Evaluation techniques such as radiography, microcomputed tomography, MRI, and ultrasound are employed to image bony and cartilaginous structures. Histological and immunohistochemical analyses provide insights into cellular and extracellular matrix changes, while gait assessments evaluate functional deficits and pain-related behaviors. Selecting an appropriate animal model requires careful consideration of research objectives, ethical standards, and translational potential. Advances in gene editing technologies (e.g. CRISPR), three-dimensional-printed implants, and in vivo imaging are enhancing model fidelity and accelerating the discovery of novel therapies. Ongoing innovations in DDH research are expected to bridge gaps in understanding the disease’s etiology and improve long-term outcomes for affected patients through optimized therapeutic interventions.
- 1 July 2025
- Published by Bioscientifica in EFORT Open Reviews
- Vol. 10 (7) , 496-509
Open AccessSelection of experimental animals and modeling methods in developmental dysplasia of the hip research
Developmental dysplasia of the hip (DDH) is a common neonatal musculoskeletal condition characterized by hip instability and inadequate acetabular coverage. If untreated, it can lead to osteoarthritis, chronic pain, and eventual hip replacement. Animal models, including dogs, pigs, sheep, rabbits, rodents, and chickens, are essential tools for studying DDH pathogenesis and testing therapeutic strategies. Larger species closely resemble human anatomy, while smaller species facilitate cost-effective, high-throughput studies and advanced genetic manipulation. Key modeling strategies include surgical interventions (e.g. joint dislocation, femoral or pelvic osteotomy), external fixation, and genetic modifications (e.g. gene knockout or lentiviral transduction) to simulate various aspects of DDH and reflect its multifactorial etiology. Evaluation techniques such as radiography, microcomputed tomography, MRI, and ultrasound are employed to image bony and cartilaginous structures. Histological and immunohistochemical analyses provide insights into cellular and extracellular matrix changes, while gait assessments evaluate functional deficits and pain-related behaviors. Selecting an appropriate animal model requires careful consideration of research objectives, ethical standards, and translational potential. Advances in gene editing technologies (e.g. CRISPR), three-dimensional-printed implants, and in vivo imaging are enhancing model fidelity and accelerating the discovery of novel therapies. Ongoing innovations in DDH research are expected to bridge gaps in understanding the disease’s etiology and improve long-term outcomes for affected patients through optimized therapeutic interventions.